We have located links that may give you full text access.
[303-POS]: Differentiation between early and late pre-eclampsia by inflammatory cytokines and the association between IL-1β and left cardiac hypertrophy.
Pregnancy Hypertension 2015 January
OBJECTIVES: To determine whether concentrations of cytokines and C-reactive protein differentiate pregnant women with early-onset preeclampsia (EOPE) from late-onset preeclampsia (LOPE), and to identify whether there is a correlation between these concentrations and left ventricular hypertrophy (LVH).
METHODS: A prospective cross-sectional study was performed with 85 pregnant women, classified into three groups: EOPE (<34 weeks of gestation, n=30), LOPE (⩾ 34 weeks, n=32) and NT (normotensive pregnant women, n=23). Pregnant women underwent echocardiography examination by the time of the PE diagnosis or when NT pregnant women were paired with PE groups. Blood levels of C-reactive protein (CRP), tumor necrosis factor alpha (TNF-α), IL-1β, IL-6 and IL-10 were analyzed. Ventricular hypertrophy was considered when the ventricular mass index was ⩾45g/m. The results were performed using nonparametric tests with a significance level set at 5%.
RESULTS: TNF-α, IL-1β and IL-6 were significantly higher in EOPE when compared with NT and LOPE. In LOPE, TNF-α and IL-6 were significantly higher when compared to the NT group. IL-10 were significantly lower whereas PCR values were significantly higher in preeclampsia women when compared with NT. Left ventricular hypertrophy was only associated with the increased concentration of IL-1β in patients of EOPE. TNF-α and IL-6 were not associated with LVH. The low concentration of IL-10 was detected in the presence of LVH in both preeclampsia groups compared absence of LVH. The concentration of CRP did not differentiate between the groups, regardless the presence of LVH.
CONCLUSIONS: These results support the hypothesis that EOPE and LOPE have different pathophysiologies, since a more intense inflammation, associated with cardiac repercussions was detected in EOPE. Moreover, the association between high concentration of IL-1β and cardiac hypertrophy suggests that this cytokine may play a relevant role in the development of this form of PE manifestation.
DISCLOSURES: V.T. Borges: None. J.C. Peraçoli: None. M. Romão: None. S. Zanati: None. J.R. Poiati: None. I.C. Weel: None. M.T. Peraçoli: None.
METHODS: A prospective cross-sectional study was performed with 85 pregnant women, classified into three groups: EOPE (<34 weeks of gestation, n=30), LOPE (⩾ 34 weeks, n=32) and NT (normotensive pregnant women, n=23). Pregnant women underwent echocardiography examination by the time of the PE diagnosis or when NT pregnant women were paired with PE groups. Blood levels of C-reactive protein (CRP), tumor necrosis factor alpha (TNF-α), IL-1β, IL-6 and IL-10 were analyzed. Ventricular hypertrophy was considered when the ventricular mass index was ⩾45g/m. The results were performed using nonparametric tests with a significance level set at 5%.
RESULTS: TNF-α, IL-1β and IL-6 were significantly higher in EOPE when compared with NT and LOPE. In LOPE, TNF-α and IL-6 were significantly higher when compared to the NT group. IL-10 were significantly lower whereas PCR values were significantly higher in preeclampsia women when compared with NT. Left ventricular hypertrophy was only associated with the increased concentration of IL-1β in patients of EOPE. TNF-α and IL-6 were not associated with LVH. The low concentration of IL-10 was detected in the presence of LVH in both preeclampsia groups compared absence of LVH. The concentration of CRP did not differentiate between the groups, regardless the presence of LVH.
CONCLUSIONS: These results support the hypothesis that EOPE and LOPE have different pathophysiologies, since a more intense inflammation, associated with cardiac repercussions was detected in EOPE. Moreover, the association between high concentration of IL-1β and cardiac hypertrophy suggests that this cytokine may play a relevant role in the development of this form of PE manifestation.
DISCLOSURES: V.T. Borges: None. J.C. Peraçoli: None. M. Romão: None. S. Zanati: None. J.R. Poiati: None. I.C. Weel: None. M.T. Peraçoli: None.
Full text links
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app